FDA-approved test for routine 3-year interval cervical cancer screening in all women ≥21 years. Acceptable for routine 3-year interval cervical cancer screening in all women 25-65 years, for whom the preferred test is Human Papillomavirus (HPV) High Risk with 16 and 18 Genotype by PCR, SurePath (2011933).
New York DOH Approval Status
Cervical specimen in a SurePath collection kit, Rovers Cervex-Brush Kit (ARUP Supply #22216), PAP Perfect Plastic Spatula and Cytobrush Plus GT Collection Kit (ARUP Supply #41126), or Rovers Cervex-Brush Combi Collection Kit (ARUP Supply #45031) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. For specific instructions refer to Specimen Collection and Handling.
Transport cervical specimen in the original collection kit.
Specimens not collected in a SurePath collection kit. Expired preservative vials or vials received without the collection devices.
Ambient: 1 month; Refrigerated: 6 months; Frozen: Unacceptable
Refer to report.
This test does not include HPV testing. The Pap test is a screening test for cervical cancer and its precursors with an inherent false-negative rate.
88142; if reviewed by pathologist add 88141
|Component Test Code*||Component Chart Name||LOINC|
|2000495||SurePath Pap Specimen Source||19763-2|
|2000496||SurePath Pap Clinical History|
- Pap Smear
- Pap Test
- SurePath Pap Test